MAY 10, 2018 07:30 AM PDT

Keynote Presentation: An Introduction to the All of Us Research Program

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Policy Director, All of Us Research Program, National Institutes of Health
    Biography
      Katherine D. Blizinsky, Ph.D, is the Policy Director for the All of Us Research Program. A neuroscientist and geneticist specializing in research on mental health and cognition, with a focus on health disparities, Dr. Blizinsky completed her doctoral work at Northwestern University. She is an alumna of the American Society of Human Genetics/National Human Genome Research Institute (NHGRI) Genetics and Public Policy Fellowship and has policy experience with both the legislative and executive branches. On Capitol Hill, Dr. Blizinsky worked with the Senate Health, Education, Labor, and Pensions (HELP) Committee under Ranking Member Patty Murray, where, among other roles, Dr. Blizinsky participated in the drafting and negotiation of the 21st Century Cures Act, which became law in 2016. Following her time on the Hill, she moved to NIH, where she held simultaneous appointments as Policy Advisor to the All of Us Research Program-concentrating on issues of data access, informed consent, and participant privacy-and as an Intramural Research Fellow with the NHGRI Health Disparities Unit under Vence L. Bonham. In addition to her current positions with All of Us and continued work with the Health Disparities Unit, Dr. Blizinsky is an Assistant Professor in the Department of Neurology at Rush University and on the faculty of the Rush Alzheimer's Disease Center in Chicago, IL.

    Abstract:

    The All of Us Research Program is a historic effort to gather data from one million or more people living in the United States to accelerate research and improve health. By taking into account individual differences in lifestyle, environment, and biology, researchers will uncover paths toward delivering precision medicine to all Americans. Today, we will discuss the program to date, considerations taken into account during its inception, lessons learned during the beta testing phase, and its trajectory into the future.


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    NOV 18, 2019 07:00 AM PST
    C.E. CREDITS
    NOV 18, 2019 07:00 AM PST
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    DEC 10, 2019 09:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 10, 2019 09:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    Loading Comments...
    Show Resources